newsfilter
← Latest News
GlobeNewswire·

Jade Biosciences to Participate in Upcoming Conferences

  • Jade Biosciences, Inc. (NASDAQ: JBIO) announced participation in four upcoming investor conferences.
  • The company will host a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8 at 3:45 p.m. ET.
  • Jade will present at the Citi 2026 Biopharma Back to School Summit on Wednesday, September 9 at 9:20 a.m. ET.
  • A fireside chat is scheduled for the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15 at 1:00 p.m. ET.
  • The Stifel Virtual Immunology & Inflammation Forum fireside chat will occur on Wednesday, September 23 at 10:30 a.m. ET.
  • Management will conduct one-on-one investor meetings during these events.
  • Live webcasts of the Wells Fargo, Citi, & H.C. Wainwright sessions will be available on the company website with replays for 90 days.
  • Jade is a clinical-stage biotech developing therapies for autoimmune diseases, with lead candidate JADE101 targeting APRIL for IgA nephropathy.
  • The pipeline includes JADE201, an anti-BAFF-R monoclonal antibody, & JADE301, an anti-IFN-β monoclonal antibody.
  • The company was launched based on assets licensed from Paragon Therapeutics.
  • The press release contains forward-looking statements regarding pipeline expectations, potential therapeutic uses, & business strategies.
  • Risks include potential delays in clinical trials, adverse safety events, unanticipated costs, & regulatory challenges.